Chronic Myeloid Leukemia
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Impact of Comorbidities in Treatment Choice of CML: TKI Toxicities Need to Be Considered, Frontline Therapy Switching/Stopping Depends on Comorbidites, Vascular Risk Major Consideration
FEATURING
Timothy P. Hughes
- 104 views
- November 18, 2019
- 1